A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 20, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Nov 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the LNSR SEC filings page.
LENSAR, Inc. (LNSR) reported $58.4M in revenue for fiscal year 2025, up 9.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue growth is being overwhelmed by expense expansion, while liabilities now exceed assets and operating cash flow has deteriorated.
From FY2024 to FY2025, revenue grew9.2% while SG&A grew70.5% , so the business added sales faster than it converted them into operating earnings. The operating-margin deterioration of 22.1 percentage points shows the cost base expanded faster than the commercial base, rather than absorbing growth efficiently.
Balance-sheet financing changed materially: total liabilities rose to
Cash conversion weakened alongside profitability: operating cash flow shifted from
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of LENSAR, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
LENSAR, Inc. held $18.0M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $14.8M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and LENSAR, Inc. scores 39/100 among other emerging companies.
Dilution ranks emerging companies on the yearly rate at which their shares outstanding grew across the last three fiscal years (the last two where the earliest reports none), a slower rise ranking higher because each round of funding spreads the same business across more owners. LENSAR, Inc. scores 74/100 on it among other emerging companies.
LENSAR, Inc. spent $5.6M on research and development in fiscal year 2025, which was 6.8% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and LENSAR, Inc. scores 30/100 among other emerging companies.
Revenue Progress ranks emerging companies on the yearly rate at which their revenue compounded across the last three fiscal years (the last two where the earliest reports none), counted in the currency each company reports in. LENSAR, Inc. scores 61/100 on it among other emerging companies.
Burn Trend ranks emerging companies on how far their operating cash flow moved between the newest fiscal year and the one two years earlier, measured against the cash the earlier year used, and a move toward generating cash ranks higher. LENSAR, Inc. scores 31/100 on it among other emerging companies.
LENSAR, Inc.'s cash, cash equivalents and investments came to $18.0M at the end of fiscal year 2025, against $83.7M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and LENSAR, Inc. scores 28/100 among other emerging companies.
LENSAR, Inc. scores -3.30, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $177.6M against total assets of $71.4M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
LENSAR, Inc. passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 operating efficiency signals passes.
LENSAR, Inc. reported a net loss of $34.3M while operations used $14.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
LENSAR, Inc. generated $14.1M in revenue in Q3 2026. This represents a decrease of 1.3% from the same quarter a year earlier. Against the prior quarter it is down 14.3%.
LENSAR, Inc.'s EBITDA was -$363K in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 111.2%.
LENSAR, Inc. reported a net loss of $4.7M in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 233.6%.
LENSAR, Inc. earned -$0.38 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Cash & Balance Sheet
LENSAR, Inc. recorded an outflow of $978K in free cash flow in Q3 2026, representing a cash shortfall after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
LENSAR, Inc. held $12.6M in cash against $1.9M in long-term debt as of Q3 2026, with $19.8M of liabilities due within a year.
Not reported for Q3 2026.
Margins & Returns
LENSAR, Inc.'s gross margin was 57.8% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 15.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.5 percentage points.
LENSAR, Inc.'s operating margin was -10.1% in Q3 2026, reflecting core business profitability. This is up 42.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 23.1 percentage points.
LENSAR, Inc.'s net profit margin was -33.4% in Q3 2026, showing the share of revenue converted to profit. This is down 7.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 54.9 percentage points.
LENSAR, Inc.'s quarterly ROE was -42.7% in Q3 2026: one quarter's net income over shareholder equity, not annualized. Against the prior quarter it is down 66.4 percentage points.
Capital Allocation
LENSAR, Inc. invested $1.3M in research and development in Q3 2026. This represents a decrease of 4.4% from the same quarter a year earlier. Against the prior quarter it is up 2.7%.
LENSAR, Inc. invested $112K in capex in Q3 2026, funding long-term assets and infrastructure. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Not reported for Q3 2026.
LNSR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.1M-1.3% | $16.5M+18.4% | $13.4M-5.2% | $16.0M-4.2% | $14.3M+5.7% | $13.9M+10.3% | $14.2M+33.7% | $16.7M+38.2% |
| Cost of Revenue | $6.0M-27.9% | $6.7M-2.8% | $7.0M+0.2% | $9.1M-5.6% | $8.3M+13.8% | $6.9M+18.7% | $7.0M+42.9% | $9.6M+38.3% |
| Gross Profit | $8.2M+35.3% | $9.8M+39.2% | $6.4M-10.4% | $6.9M-2.4% | $6.0M-3.7% | $7.0M+3.1% | $7.1M+25.8% | $7.1M+38.0% |
| R&D Expenses | $1.3M-4.4% | $1.3M-10.7% | $1.4M-9.7% | $1.3M-2.9% | $1.4M+13.7% | $1.4M+5.7% | $1.5M+6.2% | $1.3M-8.7% |
| SG&A Expenses | $8.1M-32.9% | $6.1M-47.3% | $2.5M-77.3% | $10.3M+51.2% | $12.0M+97.8% | $11.7M+71.8% | $11.1M+64.1% | $6.8M+7.2% |
| Operating Income | -$1.4Mn/m | $2.1Mn/m | $2.2Mn/m | -$4.9Mn/m | -$7.6Mn/m | -$6.3Mn/m | -$5.8Mn/m | -$1.3Mn/m |
| EBITDA | -$363Kn/m | $3.2Mn/m | $3.4Mn/m | -$3.7Mn/m | -$6.4Mn/m | -$5.2Mn/m | -$4.7Mn/m | -$184Kn/m |
| Income Tax | $0n/m | $0n/m | $0n/m | N/A | $0n/m | $0n/m | $0n/m | N/A |
| Net Income | -$4.7Mn/m | $3.5Mn/m | $36.3Mn/m | -$1.5Mn/m | -$3.7Mn/m | -$1.8Mn/m | -$27.3Mn/m | -$18.7Mn/m |
| EPS (Basic) | -$0.38n/m | $0.14 | $1.56n/m | -$0.12n/m | -$0.31n/m | -$0.15n/m | -$2.32n/m | -$1.62n/m |
| EPS (Diluted) | -$0.38n/m | $0.10 | $0.00n/m | -$0.12n/m | -$0.31n/m | -$0.15n/m | -$2.32n/m | -$1.62n/m |
| Diluted Shares (Avg) | 12M+2.9% | 23M | 15M+31.0% | N/A | 12M+3.8% | 12M+4.2% | 12M+3.4% | N/A |
Not reported in any period shown, so not listed: Interest Expense.
LNSR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $67.1M-4.5% | $69.6M-1.2% | $66.2M-9.2% | $71.4M+7.7% | $70.2M+13.2% | $70.4M+14.7% | $73.0M+10.3% | $66.3M-4.7% |
| Current Assets | $44.5M+0.1% | $47.0M+2.5% | $42.4M-13.8% | $46.8M+11.4% | $44.4M+12.8% | $45.9M+14.0% | $49.2M+15.9% | $42.0M-9.6% |
| Cash & Equivalents | $12.6M+65.3% | $13.6M+89.7% | $12.5M-36.1% | $13.0M-20.2% | $7.6M-26.9% | $7.2M-13.7% | $19.5M+40.0% | $16.3M-21.1% |
| Short-Term Investments | $0-100.0% | $0-100.0% | $1.0M-82.4% | $5.0M-19.2% | $9.2M+20.9% | $13.2M+122.1% | $5.7M+44.2% | $6.2M+79.8% |
| Inventory | $25.1M+22.1% | $24.9M+29.2% | $23.1M+50.7% | $21.5M+88.3% | $20.6M+38.3% | $19.2M+7.3% | $15.3M-14.0% | $11.4M-27.2% |
| Accounts Receivable | $5.1M-12.9% | $6.2M+23.7% | $4.9M-28.9% | $6.4M+4.8% | $5.9M+34.9% | $5.0M-15.4% | $6.9M+71.1% | $6.1M+52.1% |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0-100.0% | $0-100.0% | $0-100.0% | $0-100.0% |
| Total Liabilities | $56.0M-32.0% | $40.9M-48.7% | $55.4M-31.8% | $83.7M+36.2% | $82.3M+109.6% | $79.7M+111.0% | $81.3M+137.1% | $61.4M+174.2% |
| Current Liabilities | $19.8M-44.5% | $19.6M-34.7% | $17.8M-34.5% | $40.6M+170.4% | $35.7M+205.9% | $30.1M+190.3% | $27.2M+160.1% | $15.0M+29.0% |
| Non-Current Liabilities | $36.2M-22.3% | $21.2M-57.2% | $37.6M-30.5% | $43.1M-7.2% | $46.6M+68.8% | $49.6M+81.0% | $54.1M+127.0% | $46.4M+330.8% |
| Long-Term Debt | $1.9M | $3.8M | $5.0M | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $11.1Mn/m | $14.9Mn/m | $10.8Mn/m | -$26.0M-635.2% | -$25.9M-213.9% | -$23.1M-197.5% | -$22.1M-169.5% | $4.9M-85.5% |
| Retained Earnings | -$142.4Mn/m | -$137.7Mn/m | -$141.2Mn/m | -$177.6Mn/m | -$176.1Mn/m | -$172.4Mn/m | -$170.6Mn/m | -$143.3Mn/m |
Not reported in any period shown, so not listed: Goodwill.
LNSR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$866Kn/m | -$127Kn/m | -$4.3Mn/m | $618K-83.1% | -$3.5M-211.4% | -$5.0Mn/m | -$6.9Mn/m | $3.7Mn/m |
| Depreciation & Amortization | $1.1M-7.5% | $1.1M+1.0% | $1.1M+5.3% | $1.2M+6.1% | $1.2M+15.0% | $1.1M+21.9% | $1.1M+16.8% | $1.1M+19.7% |
| Stock-Based Compensation | $850K0.0% | $347K-54.7% | $690K+5.5% | N/A | $850K+27.2% | $766K+12.2% | $654K+0.3% | N/A |
| Capital Expenditures | $112Kn/m | N/A | N/A | $0-100.0% | $0-100.0% | $77K-31.9% | $6K-70.0% | $3K-93.3% |
| Free Cash Flow | -$978Kn/m | N/A | N/A | $618K-83.1% | -$3.5M-212.1% | -$5.1Mn/m | -$6.9Mn/m | $3.7Mn/m |
| Investing Cash Flow | -$112K-102.8% | $965Kn/m | $4.0M+653.3% | $4.2M+113.1% | $4.0Mn/m | -$7.5Mn/m | $531Kn/m | $2.0Mn/m |
| Financing Cash Flow | $35Kn/m | $233K+150.5% | -$209K-102.2% | $474K+175.6% | $0n/m | $93K-27.9% | $9.7Mn/m | $172K+17.8% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
LNSR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 57.8%+15.6pp | 59.3%+8.9pp | 47.5%-2.8pp | 43.3%+0.8pp | 42.2%-4.1pp | 50.4%-3.5pp | 50.3%-3.2pp | 42.5%-0.1pp |
| Operating Margin | -10.1%+42.8pp | 12.9%+58.1pp | 16.7%+57.6pp | -30.7%-23.0pp | -52.9%-43.8pp | -45.1%-3.3pp | -40.9%-14.0pp | -7.7%+16.8pp |
| Net Margin | -33.4%-7.5pp | 21.4%+34.1pp | 270.6% | -9.1% | -25.9%-14.9pp | -12.7%+58.9pp | -193.1% | -111.8% |
| Return on Equity | -42.7% | 23.7% | 336.7% | N/A | N/A | N/A | N/A | -384.7%-372.9pp |
| Return on Assets | -7.0%-1.8pp | 5.1%+7.6pp | 54.9%+92.3pp | -2.0%+26.2pp | -5.3%-2.9pp | -2.5%+12.2pp | -37.5%-34.2pp | -28.2%-22.6pp |
| Current Ratio | 2.25+1.0x | 2.39+0.9x | 2.38+0.6x | 1.15-1.6x | 1.24-2.1x | 1.52-2.4x | 1.81-2.3x | 2.80-1.2x |
| Debt-to-Equity | 0.17 | 0.25 | 0.46 | N/A | N/A | N/A | N/A | N/A |
| Liabilities-to-Equity | 5.06 | 2.74 | 5.14 | N/A | N/A | N/A | N/A | 12.64+12.0x |
| Asset Turnover | 0.210.0x | 0.240.0x | 0.200.0x | 0.220.0x | 0.200.0x | 0.200.0x | 0.190.0x | 0.25+0.1x |
| FCF Margin | -6.9%+17.6pp | N/A | N/A | 3.9%-18.0pp | -24.5%-47.7pp | -36.4%-5.6pp | -49.0%+1.3pp | 21.8%+26.2pp |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Note: Shareholder equity is negative (-$26.0M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| LENSAR, Inc. LNSR | FY2025 | $58.4M | -$34.3M | -58.7% | $54.8M | 44/100 |
| Hyperfine, Inc. HYPR | FY2025 | $13.6M | -$35.6M | N/A | $58.0M | 58/100 |
| Outset Medical, Inc. OM | FY2025 | $119.5M | -$81.7M | -68.3% | $53.0M | 58/100 |
| Envoy Medical, Inc. COCH | FY2025 | $241K | -$23.8M | N/A | $51.9M | — |
| Lucid Diagnostics Inc. LUCD | FY2025 | $4.7M | -$58.0M | N/A | $72.6M | 42/100 |
| Sera Prognostics, Inc. SERA | FY2025 | $81K | -$31.9M | N/A | $72.0M | — |
Where LENSAR, Inc. Ranks
Frequently Asked Questions
LENSAR, Inc. (LNSR) reported $58.4M in total revenue for fiscal year 2025. This represents a 9.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
LENSAR, Inc. (LNSR) revenue grew by 9.2% year-over-year, from $53.5M to $58.4M in fiscal year 2025.
No, LENSAR, Inc. (LNSR) reported a net loss of $34.3M in fiscal year 2025, with a net profit margin of -58.7%.
LENSAR, Inc. (LNSR) had EBITDA of -$20.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
LENSAR, Inc. (LNSR) had a gross margin of 46.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
LENSAR, Inc. (LNSR) had an operating margin of -42.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
LENSAR, Inc. (LNSR) had a net profit margin of -58.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
LENSAR, Inc. (LNSR) recorded an outflow of $14.9M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
LENSAR, Inc. (LNSR) recorded an outflow of $14.8M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
LENSAR, Inc. (LNSR) had $71.4M in total assets as of fiscal year 2025, including both current and long-term assets.
LENSAR, Inc. (LNSR) invested $83K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
LENSAR, Inc. (LNSR) invested $5.6M in research and development during fiscal year 2025.
LENSAR, Inc. (LNSR) had a current ratio of 1.15 as of fiscal year 2025, which is considered adequate.
LENSAR, Inc. (LNSR) had a return on assets of -48.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
LENSAR, Inc. (LNSR) trades at 1.6x earnings, its market capitalization divided by $33.7M net income, trailing 12 months to September 30, 2026. The market capitalization is $54.8M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
LENSAR, Inc. (LNSR) trades at 0.9x sales, its market capitalization divided by $60.1M revenue, trailing 12 months to September 30, 2026. The market capitalization is $54.8M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
At the end of fiscal year 2025, LENSAR, Inc. (LNSR) held $18.0M in cash, cash equivalents and investments, and reported an operating cash outflow of $14.8M over that year. Dividing the one by the other, the reported balance equals about 15 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
LENSAR, Inc. (LNSR) has negative shareholder equity of -$26.0M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
LENSAR, Inc. (LNSR) has an Altman Z-Score of -3.30, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
LENSAR, Inc. (LNSR) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
LENSAR, Inc. (LNSR) reported a net loss of $34.3M while operations used $14.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
LENSAR, Inc. (LNSR) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.